Bär & Karrer Advised Lead Investor
Revival Healthcare Capital on the USD
150 Million Series G Financing Round of
Swiss Medtech Company Distalmotion

Revival Healthcare Capital and Distalmotion SA, a global medical device company based in Lausanne and empowering access to the benefits of robotic surgery in outpatient sites of care, announced the successful closing of a USD 150 million Series G financing round of Distalmotion SA led by Revival Healthcare Capital, with participation from existing investors. The financing is designed to accelerate US commercial adoption of the company's surgical robot "Dexter", its soft tissue robotic surgery system, as well as to support ongoing clinical and product development initiatives. Revival Healthcare Capital is a US based healthcare sector investor specialized in medical devices and diagnostics which works collaboratively with companies on enabling equity transactions that support a broad range of potential growth strategies, including commercial scale strategies, strategic growth opportunities and special opportunities strategies.

Bär & Karrer acted as Swiss legal adviser to Revival Healthcare Capital in this transaction, alongside Wilson Sonsini. The team was led by Martin Anderson and included Taulant Dervishaj and Bruno Perriard (all M&A/Corporate), Frédéric Bétrisey (Banking & Finance), and Christoph Suter and Alice Johnson (both Tax).